Muen Biomedical and Optoelectronic Technologies Inc. Officially Announces Medical Device Registration Approval in Vietnam and Thailand
Muen Biomedical and Optoelectronic Technologies Inc. (MUEN) is pleased to announce that two of its core AI-powered medical device software products, both certified by Taiwan’s Food and Drug Administration (TFDA), have successfully obtained medical device registration approval in Vietnam and Thailand, officially granting market access in both countries.
The approved products include Muen Lung CT Image Processing Software (MAIA Lung LDCT, TFDA License No. 007448), and Muen Liver CT Image Processing Software (MAIA Liver CT, TFDA License No. 008151).
This important milestone not only demonstrates MUEN’s technological capabilities in the field of AI-assisted medical imaging, but also reflects international regulatory recognition of the company’s solutions. It further marks MUEN’s strong commitment to expanding its presence across the Southeast Asian healthcare market.
AI-Assisted Precision Diagnosis to Optimize Clinical Workflows
As global demand for precision medicine continues to grow, fast and accurate interpretation of medical imaging has become essential in clinical diagnosis and treatment. The two flagship products approved for entry into the Southeast Asian market are designed to provide practical clinical support for local healthcare institutions.
MAIA Lung LDCT
Rapid Lesion Localization:
Powered by lung segmentation and YOLO technologies, MAIA Lung LDCT can automatically and efficiently identify image slices containing lung nodules. This assists physicians in quickly locating suspicious lesions and significantly reduces visual fatigue during manual image review.
Automated Report Generation:
The system is equipped with automated report generation capabilities and is designed to comply with the reporting format required by Taiwan’s Health Promotion Administration. This helps greatly reduce the documentation workload for physicians after image interpretation.
MAIA Liver CT
Precise Marking and Reduced Misinterpretation:
Using a single U-NET multi-label segmentation model and multi-slice input technology, MAIA Liver CT can accurately identify and automatically mark liver nodules, while effectively reducing false positives caused by blood vessels and other anatomical structures.
Enhanced Clinical Decision-Making:
Through robust and stable automated marking and computational functions, the system helps medical teams gain a more intuitive understanding of disease progression, improving diagnostic efficiency and the quality of doctor-patient communication.
Deepening Our Presence in Asia, Expanding Toward the Global Market
Obtaining medical device approval in Vietnam and Thailand represents a key foundation for MUEN’s expansion into the ASEAN market. Moving forward, MUEN will continue to collaborate with local healthcare institutions and strategic partners to promote the adoption and exchange of AI medical software solutions.
Guided by a commitment to innovation and rigorous research and development, MUEN will continue to optimize and expand its intelligent healthcare product portfolio. The company aims to bring high-quality AI medical solutions from Taiwan to the global market, benefiting more patients worldwide.
For more information about our products or overseas business collaboration opportunities, please contact the MUEN team.
.png)